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Abstract
Background: To investigate the clinical features of corneal opacity and the surgical outcome of penetrating
keratoplasty (PK) in eyes with congenital glaucoma.
Methods: A retrospective review was made of the records from 320 eyes of 193 patients who were diagnosed with
congenital glaucoma between January 1981 and January 2016. Anterior segment photographs at disease
presentation were examined for the presence and severity of corneal opacity. Data on patient demographics,
intraocular pressure (IOP), ocular and systemic comorbidities, ocular surgery and its outcome were collected.
Results: Overall, corneal opacification was observed in 248 of 320 eyes (77.5%). Out of 248 eyes with corneal
opacification, 53 eyes had Haab striae alone, and 195 eyes presented with either nebulomacular corneal opacity
(128 eyes, iris details visible through opacity) or leukomatous corneal opacity (67 eyes, iris details invisible through
opacity). In 12 eyes with severe leukomatous corneal opacity, PK was performed at the mean age of 18.6 months
(range 4–57 months). The grafts failed in 6 eyes (50%) due to endothelial rejection (4 eyes) or graft infection (2
eyes) during the mean 80.6 months of follow-up (range 15–228 months). The median survival time was 36 months.
The graft failure was significantly associated with smaller corneal diameter at the time of surgery, but not with the
age, IOP, combined aniridia, simultaneous glaucoma or lens surgery.
Conclusion: Congenital glaucoma was combined with corneal opacity in 77.5%. The corneal transplant survival was
50% in eyes with congenital glaucoma and total corneal opacity.
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Background
Congenital glaucoma (CG) is a rare disease with the in-
cidence largely varying upon the ethnicity [1–3]. Studies
reported that the annual incidence of CG was 2.85 to
5.41 in 100,000 live births in Caucasian populations [3,
4], whereas it was higher in South Asian children [3].
Despite its rarity, CG is often associated with poor visual
and functional outcome [5, 6], and it is estimated that
glaucoma is responsible for 4–18% of childhood blind-
ness [3, 6–8]. Hence, early detection of the disease and
proper treatment are necessary for the vision in pediatric
patients with CG.
The classical triad of symptoms in congenital glau-
coma includes epiphora, photophobia, and blepharo-
spasm [1]. However, the most common signs first
recognized by parents or doctors are corneal abnormal-
ities such as corneal enlargement (buphthalmos) due to
increased intraocular pressure (IOP) or corneal clouding
as a result of Descemet’s membrane tears (Haab striae)
or stromal edema [9–13]. In addition, as it is one form
of developmental anomaly of anterior segment, CG is
often combined with corneal opacity as a sequel to an-
terior segment dysgenesis. In these cases, corneal opacity
can lead to sensory deprivation amblyopia, and the vis-
ual outcome can be poor despite optimal control of IOP.
One study reported that corneal opacity along with
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anisometropia was responsible for vision loss in 50% of
childhood glaucoma patients [14]. Therefore, evaluation
for corneal opacity and its management are critical for
early diagnosis of the disease and the favorable outcome
in patients with CG.
We performed this study to evaluate the incidence and
clinical characteristics of corneal opacity combined with
CG and to investigate the surgical outcome of penetrat-
ing keratoplasty (PK) and clinical factors affecting the
outcome in eyes with CG.
Methods
This retrospective study was approved by the Institu-
tional Review Board (IRB No. 1706–094-860). Medical
records were reviewed for 320 eyes of 193 Korean pa-
tients who were diagnosed with CG between January
1981 and January 2016.
The diagnosis of CG was taken as recorded in the
charts. The diagnosis was usually made on the basis of
two or more of the following ocular findings: elevated
IOP (> 21 mmHg), buphthalmos (enlarged corneal diam-
eter, Fig. 1a), Haab striae, corneal stromal edema, and
glaucomatous optic disc change which had been present
at birth or shortly after birth. Glaucoma of childhood or
juvenile onset was excluded.
Data collected were the patient demographics, laterality of
disease, IOP, corneal diameter, ocular comorbidities (aniri-
dia, Peters anomaly, cataract, posterior segment anomalies),
systemic abnormalities (Sturge-Weber syndrome, neuro-
fibromatosis, congenital heart disease, TORCH positivity,
cerebral palsy, Wilms tumor, chromosomal anomaly), ocular
surgery (PK, glaucoma surgery, lens extraction), and
last-recorded visual acuity.
In addition, anterior segment photographs at first
presentation of a patient were reviewed for the presence
of corneal opacity, and the corneal findings were classi-
fied as follows: 1) completely clear cornea, 2) Haab striae
only (Fig. 1b, c), and 3) corneal opacity. The severity of
corneal opacity was further graded based on both
four-stage system and two-scale system. The four-stage
system followed the corneal opacity scoring system sug-
gested by Gupta et al. [15, 16] with modification: stage 1
=minimal opacity (Fig. 1d), stage 2 =moderate stromal
opacity (anterior chamber and iris both well visualized,
Fig. 1e), stage 3 = significant stromal opacity (pupil vis-
ible with haze, Fig. 1f ), and stage 4 = intense stromal
opacity (pupil invisible, Fig. 1g). The two-scale system
was composed of nebulomacular corneal opacity (iris de-
tails visible through opacity) and leukomatous corneal
opacity (unable to visualize iris details through opacity).
Overall, nebulomacular corneal opacity included stage 1
and 2 opacities, and leukomatous corneal opacity com-
prised stage 3 and 4 opacities.
The data were additionally analyzed in 12 eyes of 10
CG patients with stage 4 corneal opacity who underwent
PK. The graft failure was determined when corneal clar-
ity was irreversibly lost under slit-lamp examination, and
the graft survival time was defined as the period from
PK to the day when the graft failure was first noted.
When multiple PKs were performed in a patient, the
first surgery was taken for analysis. The association of
age, IOP at the time of surgery, corneal diameter, donor/
recipient trephine sizes, difference of sizes between
donor and recipient trephines, presence of ocular co-
morbidities, and concurrent lens or glaucoma surgeries
with corneal graft outcome was evaluated.
Data were presented as mean ± SD. The GraphPad
Software (GraphPad Prism, La Jolla, CA) was used for
statistical analysis. Comparison of quantitative variables
between two groups was made by using Student t test.
The correlation between IOP and the severity of corneal
opacity was tested by using Pearson r coefficient and
two-tailed P value. Survival analysis was performed using
the Kaplan–Meier method to estimate the median time
Fig. 1 Representative photographs of corneal abnormalities associated with congenital glaucoma. a Enlarged cornea (buphthalmos) in the right
eye with congenital glaucoma. b, c Horizontal lines of Haab striae are present in the cornea. d Grade 1 corneal opacity. Minimal and superficial
opacity is observed. e Grade 2 corneal stromal opacity. Both anterior chamber and iris are well-visible despite the opacity. f Grade 3 corneal
stromal opacity. The pupil is still visible but iris details difficult to see through the opacity. g Grade 4 corneal stromal opacity. Pupil is invisible due
to total stromal opacity of the cornea
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to graft failure. The association with the surgical out-
come and each clinical factor was analyzed using Fisher’s
exact test for qualitative variables and two-tailed Student
t test for quantitative variables. A P value < 0.05 was
considered statistically significant.
Results
Demographical, ocular and systemic features of CG
patients
The demographical, ocular and systemic findings of pa-
tients are summarized in Table 1. Of a total 320 eyes in
193 Korean patients with CG, 116 patients (60.1%) were
male and 77 (39.9%) were female. The disease was bilat-
eral in 127 patients (65.8%) and unilateral in 66 patients
(34.2%) (Right: Left = 26: 40).
The IOP at first presentation was 28.3 ± 9.3 mmHg
(range 9.0–54.7 mmHg) in eyes with CG and 12.9 ±
2.9 mmHg (range 6.0–29.0 mmHg) in eyes without CG
(P < 0.0001). The horizontal corneal diameter was 12.5
± 1.2 mm (range 7.0–16.5 mm) at presentation in eyes
with CG, which was significantly larger than that of the
eye without CG (10.9 ± 0.9 mm, range 9.0–11.5 mm) in the
same population (P < 0.0001). Thirty-six patients (18.7%)
had systemic diseases. Sturge-Weber syndrome was the
most common anomaly combined with CG (n = 25, 12.9%).
Other systemic comorbidities included congenital heart dis-
ease (n= 4, 2.1%), neurofibromatosis (n = 2, 1.0%), TORCH
positivity (n = 2, 1.0%), cerebral palsy (n = 1, 0.5%),
Wilms tumor (n = 1, 0.5%), and chromosomal anom-
aly (n = 1, 0.5%).
Congenital ocular comorbidities were observed in 38
patients (19.7%) and included aniridia (n = 14, 7.3%), Pe-
ters anomaly (n = 7, 3.6%), congenital cataract (n = 4,
2.1%), and posterior segment anomaly (n = 13, 6.7%).
Corneal opacification combined with CG
Overall, corneal opacification was observed in 248 of
320 eyes with CG (77.5%), while the cornea was com-
pletely clear in 72 eyes (22.5%) (Table 2). Among 248
eyes with corneal opacification, 53 (16.6%) had only
Haab striae in the cornea (Fig. 1b, c), and 195 (60.9%)
had corneal opacity in the presence or absence of Haab
striae (Table 2). The severity of corneal opacity in 195
CG eyes combined with corneal opacity was as follows:
grade 1 in 68 eyes (21.2%, Fig. 1d), grade 2 in 60 eyes
(18.8%, Fig. 1e), grade 3 in 31 eyes (9.7%, Fig. 1f ), and
grade 4 in 36 eyes (11.2%, Fig. 1g). When classified based
on the two-scale system, nebulomacular corneal opacity
was observed in 128 eyes (40%), and leukomatous cor-
neal opacity in 67 eyes (20.9%) (Table 2). There was no
significant correlation between the severity of corneal
opacity and IOP (R = 0.012, P = 0.887).
Table 1 Demographics and clinical feature of patients with
congenital glaucoma (193 patients, 320 eyes)






Unilateral Rt 26 13.5
Lt 40 20.7
IOP of involved eyes at presentation (mmHg)
Involved eyes (range) 28.3 ± 9.3 (9.0–54.7)
Uninvolved eyes (range) 12.9 ± 2.9 (6.0–29.0)
P value < 0.0001
Corneal diameter (Horizontal, mm)
Involved eyes (range) 12.5 ± 1.2 (7.0–16.5)
Uninvolved eyes (range)) 10.9 ± 0.9 (9.0–11.5)
P value < 0.0001
Systemic comorbidity 36 18.7
Sturge-Weber syndrome 25 12.9
Congenital heart disease 4 2.1
Neurofibromatosis 2 1.0
TORCH 2 1.0
Cerebral palsy 1 0.5
Wilms tumor 1 0.5
Chromosomal abnormality 1 0.5
Ocular comorbidity 38 19.7
Aniridia 14 7.3
Peters anomaly 7 3.6
Cataract 4 2.1
Posterior segment anomaly 13 6.7
Table 2 Keratopathy combined with congenital glaucoma (320
eyes)
Corneal findings No of eyes (%) IOP (mmHg, range)
Completely clear cornea 72 (22.5) 24.0 ± 7.8
(11.0–42.1)
Haab striae only 53 (16.6) 24.3 ± 9.7
(11.0–46.0)
Corneal opacification ± Haab striae 195 (60.9) 28.3 ± 9.9
(9.0–54.7)
Nebulomacular opacity Grade 1 68 (21.2) 27.1 ± 10.6
(9.0–50.0)
Grade 2 60 (18.8) 28.5 ± 10.3
(13.0–54.7)
Leukomatous opacity Grade 3 31 (9.7) 30.5 ± 7.6
(17.0–43.0)
Grade 4 36 (11.2) 28.6 ± 10.1
(9.0–47.0)
IOP Intraocular pressure
Kim et al. BMC Ophthalmology  (2018) 18:190 Page 3 of 6
Surgical outcome of corneal transplantation in eyes with
CG
We additionally analyzed the data of 12 eyes (10 pa-
tients) that underwent PK because of non-resolving
grade 4 leukomatous corneal stromal opacity. Eight pa-
tients had PK in one eye, and 2 underwent PK in both
eyes. The demographical, clinical and surgical data are
shown in Table 3. The patients included 4 female and 6
male. CG was bilateral in 2 patients and unilateral in 8
patients (Right: Left = 2: 6). The age at time of PK was
18.6 ± 17.8 months (range 4 to 57 months). Aniridia was
combined in 7 eyes (5 with total aniridia and 2 with par-
tial aniridia), Peters anomaly in 5 eyes, cataract in 1 eye,
and posterior segment abnormality (retinopathy of pre-
maturity) in 1 eye.
The IOP at time of surgery was 35.5 ± 9.3 mmHg
(range 20.0–47.8 mmHg), and all eyes were treated with
multiple anti-glaucoma medications. The corneal diame-
ters measured at the time of PK were 11.7 ± 1.8 mm
(range 9.5–15.0 mm) horizontally and 10.7 ± 1.7 mm
(range 9.0–14.0 mm) vertically. The sizes of trephines
used for PK were 6.9 ± 0.8 mm (range 6.0–8.0 mm) for
recipient beds and 7.5 ± 0.7 mm (range 6.5–8.5 mm) for
donor buttons. In 4 eyes, glaucoma valve implantation
surgery was simultaneously performed with PK, and in 3
eyes, lens extraction was done in an open-sky manner
during PK.
Over the mean 80.6 ± 77.8 months of follow-up (range
15–228 months), the corneal grafts failed in 6 eyes (50%)
whereas they survived in 6 eyes (50%) (Fig. 2). The mean
time to graft failure after PK was 7.3 ± 3.5 months (range
1–10 months) in patients with graft failure (Fig. 2), and
the mean postoperative follow-up period in those with
graft success was 38.2 ± 17.2 months (range 16–
62 months). The median survival time of the grafts was
36 months. Out of 6 eyes with graft failure, 4 were
caused by endothelial rejection, and 2 were due to graft
infection. Among 6 eyes with graft failure, a repeat PK
was performed in 4 eyes, 3 of which (66.7%) had the
graft failure after regrafting (2 eyes with endothelial re-
jection and 1 with graft infection), an indication that the
outcome of a repeat PK was worse than that of the first
surgery. Overall, 4 out of 12 eyes with PK (33.3%)
achieved ambulatory vision at the last follow-up as de-
fined by the ability to fixate and follow targets or to
count fingers at 3 ft or better [17].
Various clinical and surgical factors were analyzed for
their association with corneal graft outcome. Of the fac-
tors examined, a smaller diameter of the cornea at the
Table 3 Demographics, clinical and surgical features of patients
with penetrating keratoplasty (n = 10, 12 eyes)
Clinical or surgical parameters
Gender (No of patients, %)
Female 4 (40%)
Male 6 (60%)
Laterality (No of patients, %)
Bilateral 2 (20%)
Unilateral Rt 2 (20%)
Lt 6 (60%)
Age at time of surgery (months, range) 18.6 ± 17.8 (4–57)
The postoperative follow-up (months, range) 80.6 ± 77.8 (15–228)
Systemic comorbidity (No of patients, %)
Congenital heart disease 1 (10%)
Ocular comorbidity (No of eyes, %)
Aniridia Total 5 (41.7%)
2 (16.7%)
Partial
Peters anomaly 5 (41.7%)
Cataract 1 (8.3%)
Retinopathy of prematurity 1 (8.3%)
IOP at time of surgery (mmHg, range) 35.5 ± 9.3 (20.0–47.8)
Corneal diameter (mm, range)
Horizontal 11.7 ± 1.8 (9.5–15.0)
Vertical 10.7 ± 1.7 (9.0–14.0)
Trephine diameter (mm, range)
Recipient 6.9 ± 0.8 (6.0–8.0)
Donor 7.5 ± 0.7 (6.5–8.5)
Concurrent surgery (No of eyes, %)
Glaucoma surgery (valve surgery) 4 (33.3%)
Lens extraction 3 (25%)
IOP Intraocular pressure
Fig. 2 The Kaplan-Meier survival curve of primary penetrating
keratoplasty in patients with congenital glaucoma. Out of 12 corneal
grafts, 6 failed within 10 months after surgery (range 1–10 months)
during the mean 80.6 months of follow-up (range 15–228 months).
One year graft survival probability was 50%, and the median survival
time of the grafts was 36 months
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time of surgery was significantly associated with the graft
failure. The horizontal corneal diameters were 12.8 ±
1.7 mm in the survival group and 10.4 ± 0.9 mm in the
failure group (P = 0.0126, Table 4). However, there were
no significant associations between the graft survival and
other factors such as the age, IOP, the presence of aniri-
dia or Peters anomaly, the difference of sizes between
donor and recipient trephines, and simultaneous glau-
coma or lens surgery (Table 4).
Discussion
Corneal findings are important for suspicion and diagnosis
of CG. Studies reported that cloudy cornea and buphthal-
mos are the most common presenting signs found in over
40% of patients with CG [11, 12]. In our study, 248 of 320
eyes (77.5%) with CG had corneal opacification at disease
presentation, whereas 22.5% had completely clear cornea.
However, among 77.5% of CG eyes with corneal opacity,
16.6% presented with Haab striae alone and 21.2% had
grade 1 minimal opacity. Therefore, visually significant
and recognizable corneal opacity (grade 2, 3 or 4 opacity)
was observed in 39.7% of the eyes with CG, which is simi-
lar to previous reports [11] [12].
Other notable findings of our study are that male was
more prevalent than female in CG patients at a ratio of
60.1 to 39.9, and bilateral involvement was more com-
mon compared to unilateral involvement at a ratio of
65.8 to 34.2. Overall, 18.7% of CG patients had
combined systemic diseases, and the most common sys-
temic comorbidity was Sturge-Weber syndrome which
was found in 12.9% of patients with CG. However,
Sturge-Weber syndrome was not associated with severe
corneal opacity since no patient with Sturge-Weber syn-
drome underwent PK because of corneal opacity. Neuro-
fibromatosis was combined in two patients (1.0%) in our
study. Quaranta et al. [18] reported that neurofibroma-
tosis patients showed gonioscopic findings characteristic
of underdevelopment of the iridocorneal angle, suggest-
ing the vulnerability to glaucoma. Of ocular morbidities
combined with CG, aniridia was the most frequent
(found in 7.3% of CG patients), followed by Peters
anomaly (found in 3.6% of CG patients). Combined anir-
idia and Peters anomaly predisposed patients with CG to
severe non-resolving corneal opacity which required PK.
Seven out of 14 patients with CG + aniridia and 5 of 7
patients with CG + Peters anomaly underwent PK.
It is generally accepted that the presence of glaucoma
and concurrent glaucoma operation during PK are risk
factors for poor graft survival in a pediatric population
[19, 20]. However, there have just a few case series evaluat-
ing the surgical outcome of PK in CG patients, and the re-
sults greatly vary upon studies. In our study, the overall
graft survival rate was 50% (6 of 12) in eyes with CG dur-
ing a mean follow-up of 80.6 months, and 33.3% of pa-
tients with PK achieved ambulatory vision at the last
follow-up. Of note, in the graft failure group, all grafts
failed within 10 months (at the mean 7.3 months) after
PK. Ariyasu et al. [21] reported that the graft success oc-
curred in 67% of grafts (6 of 9) in eyes with CG during
24 months of follow-up, and ambulatory vision was
achieved in 75% of eyes. In a report by Al-Torbak [22], 43
and 17% of corneal grafts survived at 24 and 48 months,
respectively after combined PK and Ahmed valve implant-
ation. In our patients, PK was combined with glaucoma
valve implantation in 4 eyes, 3 of which had graft failure.
By contrast, 3 of 8 eyes without glaucoma surgery had
graft failure. This suggests that concurrent glaucoma valve
implant surgery might be associated with poor graft out-
come, although it did not reach statistical significance due
to the small sample size of the current study. Further
study with larger sample size would be necessary to con-
firm the effect of simultaneous glaucoma surgery on the
corneal transplant survival.
The only variable affecting the graft outcome was the
corneal diameter in our study. The cornea was signifi-
cantly smaller in the graft failure group, compared to the
graft success group. This result is consistent with our
previous findings in patients with Peters anomaly or
sclerocornea [23]. The proximity of the donor graft to
the recipient limbus and more exposure to the host im-
mune system might be related to the high rate of graft
failure in eyes with smaller corneas.
Table 4 Comparison of clinical and surgical factors between
the graft survival and failure groups
Graft survival Graft failure P value
Aniridia (No. of eyes)
O 5 2 0.2424
X 1 4
Peters anomaly (No. of eyes)
O 4 1 0.2424
X 2 5
Concurrrent glaucoma surgery (No. of eyes)
O 1 3 0.5455
X 5 3
Concurrrent lens extraction (No. of eyes) 1
O 1 2
X 5 4
Corneal diameter (horizontal, mm) 12.8 ± 1.7 10.4 ± 0.9 0.0126
Corneal diameter (vertical, mm) 11.7 ± 1.9 9.6 ± 0.9 0.0354
Age at time of surgery (months) 21.7 ± 15.8 15.5 ± 20.7 0.5739
IOP at time of surgery (mmHg) 36.1 ± 12.5 34.9 ± 5.8 0.8373
Trephine gappinga (mm) 0.54 ± 0.3 0.46 ± 0.4 0.8312
aTrephine gapping means the size difference between donor and
recipient trephines
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Our study is limited by its retrospective nature. Al-
though we here presented the data on corneal opacity de-
termined from the corneal photography in 320 eyes of 193
patients, it was not possible to evaluate other corneal ab-
normalities such as topographic changes, endothelial cell
counts, or hysteresis. Since it was reported that corneal
topographic abnormalities were commonly present in CG
[13], further prospective study evaluating the cornea from
multiple aspects would be helpful to better understand
corneal anomalies associated with CG.
Conclusion
Corneal opacity was a common feature of CG and found
in 77.5% of CG patients. The survival rate of corneal al-
lografts in eyes with CG and severe stromal opacity was
50%, and the graft outcome was poorer in eyes with
small corneal diameters.
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